4
Changes in Ownership
Gossamer Bio, Inc. Filed Acc 0001728117-23-000028
Options or other derivatives
- Chief Scientific Officer acquired 157,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Carter Laura Chief Scientific Officer | 2023-03-20 | Grant or award · Stock Option (Right to Buy) | +157,500 | 157,500 | D: show line 1 in the form |
Loading xslF345X04/wf-form4_167952019155286.xml…